# ZeoVation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zeovation

- Industry: Biotechnology
- Headquarters: Columbus, US
- Website: www.zeovation.com
- Total disclosed funding: $0.3M
- Latest round: Seed (May 23, 2017)
- Investors on record: 1

## About

ZeoVation Inc. focuses on developing innovative zeolite-based products, providing antimicrobial and antiviral solutions that enhance safety in various manufacturing processes across multiple industries.Founded in 2017, ZeoVation Inc. operates from its headquarters in Columbus, US, specializing in advanced zeolite technologies. The firm was established by Bo Wang and Prabir Dutta, with Bo Wang serving as the CEO. ZeoVation has secured a total of USD 0.30 mn across two funding deals, with the most recent being a VENTURE DEBT round of USD 0.22 mn on June 30, 2019.ZeoVation specializes in the development and supply of innovative zeolite-based products, focusing on controlled release "smart" particles that can be incorporated into various manufacturing processes. Their core offerings include antimicrobial and antiviral additives that enhance surface cleanliness and safety in applications such as medical devices, paints and coatings, plastics and polymers, textiles, and battery separation. Utilizing patent-pending technology, these products provide a continuous antimicrobial effect, preventing pathogen growth and ensuring long-lasting efficacy for clients across North America, Europe, and Asia.ZeoVation's revenue generation is primarily driven by B2B transactions, supplying antimicrobial additives and colloidal zeolites directly to manufacturers. The company collaborates with clients to customize solutions to meet specific application needs, fostering long-term relationships. Revenue is generated from bulk orders, with pricing structures reflecting the complexity of the tailored solutions provided. Clients include large-scale manufacturers in the medical and industrial sectors who incorporate ZeoVation's products into their production lines, supporting a recurring revenue model based on ongoing supply agreements and product development collaborations.ZeoVation plans to utilize the recent VENTURE DEBT round of USD 0.22 mn to support the development of new zeolite-based products targeting additional applications within the medical and industrial sectors. The company is also exploring expansion into new markets across Asia and Europe by 2023, aiming to increase their global footprint and client base. The funding will facilitate product innovation and market entry strategies for enhanced growth.

## Funding rounds

- Seed, May 23, 2017, $0.3M — Rev1 Ventures

## Investors

- Rev1 Ventures (https://capitalatlas.ai/funds/rev1-ventures) — Seed